Joshua Sachs is a director in the Healthcare Investment Banking team at Raymond James, based in Frankfurt, Germany. He joined the firm in 2024 and focuses primarily on advising clients on mergers and acquisitions across the life sciences and healthtech sectors.
Joshua brings over a decade of experience in the healthcare industry, with transaction and advisory expertise spanning (bio-)pharma, life science tools, pharma services, bioinformatics and digital health. Prior to joining Raymond James, he began his career in the pharmaceutical industry at Roche and subsequently worked in consulting at PwC and investment banking at Cowen.
A scientist by training, Joshua holds a master’s degree in life sciences from Imperial College London and a bachelor’s degree in molecular biotechnology from Heidelberg University.